Across Africa and other emerging markets, the opportunity to get healthcare technology right from the start is real. Governments and health systems are making platform decisions today that will shape clinical care for the next 20 years. The advisory challenge is not optimization of a mature system. It is making the right foundational choices before they become hard to reverse.
The experience of building healthcare technology in the GCC, a region that moved from low digital maturity to sophisticated clinical infrastructure in under a decade, is directly transferable.
Most healthcare technology advisory is built around mature markets: optimizing existing deployments, navigating vendor relationships, extracting ROI from sunk investments. That is not the starting point for a government health authority in Ghana or a new private hospital group in Angola.
The starting point is: what platform do we select, how do we govern the implementation, how do we build internal capability so we are not permanently dependent on external support, and how do we deploy clinical AI in an environment where the data infrastructure is still being built.
These are the questions this practice is designed to answer. Vendor-agnostic, operator-led, and built on direct experience of doing this in a market that faced the same questions not long ago.
Engagements are available across the following markets. Remote advisory is available for all. In-country work is available on request.
West Africa
East Africa
Southern and Central Africa
Other Emerging Markets
From the first platform decision through to enterprise AI deployment. All engagements are advisory-first and vendor-agnostic.
For governments, ministries of health, and hospital groups evaluating their first or replacement EMR. The advice is independent. There is no commercial relationship with any platform vendor.
Scope covers: Requirements definition, vendor landscape assessment, evaluation criteria, procurement process design, contract negotiation support, and implementation readiness planning.
Experience spans Oracle Health, open-source platforms, and mid-market solutions relevant to emerging market budgets and infrastructure constraints.
For health systems that have selected a platform and need independent oversight of the implementation. Vendor implementations in emerging markets carry specific risks: scope creep, localisation gaps, and handover to teams that were not adequately prepared.
Approach: Independent project governance, milestone verification, risk identification, and building internal capability in parallel with the implementation so the organisation is not permanently dependent on vendor support.
For government health authorities and large health systems developing a multi-year digital health strategy. The starting point is clinical and operational need, not technology for its own sake.
Output: A prioritised roadmap with realistic budgets, sequencing logic, build-versus-buy decisions, and a governance framework that survives changes in leadership and funding cycles.
AI deployment in emerging markets is not a scaled-down version of what works in the GCC or Europe. Data infrastructure, connectivity, clinical workflow, and change management are all different constraints.
Focus areas: Diagnostic AI where radiologist access is limited, ambient documentation where administrative burden falls on clinicians directly, and decision support that works within existing workflow rather than requiring it to change first.
For development finance institutions, impact investors, and PE firms making healthcare technology investments in emerging markets. Understanding whether a technology platform is fit for purpose in a specific market context requires operator experience, not just financial analysis.
Covers: Platform assessment, implementation risk, vendor dependency, scalability across low-resource environments, and realistic timelines for technology ROI.
For health systems that want to build their own technology leadership rather than remain permanently dependent on external advisors and vendors. This is the long-term play that most technology programmes in emerging markets miss.
Approach: Structured knowledge transfer, clinical informatics training, and building the internal governance structures that allow a health system to manage its own technology roadmap over time.
The problems are structurally similar: greenfield decisions, government and private investment coming in simultaneously, vendor pressure to lock in platforms early, and a shortage of experienced operators to govern the process.
Having built clinical technology infrastructure from early-stage deployments across the GCC, the patterns of what goes wrong in greenfield implementations are well understood. Most of them are avoidable with the right governance in place early.
No commercial relationship with any EMR vendor, implementation partner, or technology reseller. The advice is independent. In a market where vendors are actively competing for long-term contracts, that independence has real value.
Experience working with government health authorities, semi-government organisations, and DHA-regulated environments in the UAE. Understanding how public sector procurement, governance, and decision-making works is directly applicable.
Advisory covers the complete technology environment: ERP, supply chain, laboratory, pharmacy, radiology, and integration architecture. Healthcare in emerging markets requires a systems view, not a single platform focus.
Hands-on experience building clinical applications, supply chain tools, and AI integrations that solve real operational problems. In markets where off-the-shelf solutions do not fit, knowing what is actually buildable matters.
The UAE and broader GCC have completed a healthcare digitisation journey that African markets are beginning. Access to that reference experience, including what worked, what did not, and what the vendors said versus what they delivered, is directly useful.
Outcomes from healthcare technology engagements across the GCC, India, and APAC. The same operator experience now available to emerging markets.
Oracle Health deployments and optimisation engagements across government, semi-government, and private healthcare organisations.
Oracle Health Millennium migrated to Oracle Cloud Infrastructure at King's College Hospital Dubai. Zero clinical downtime.
Enterprise AI rollout across a multi-site health system. Documentation quality improved and administrative burden measurably reduced.
Digital platform delivering measurable financial impact through omnichannel patient experience without replacing the EMR.
Fujifilm PACS implementation led personally from contract to go-live. Radiology turnaround time reduced 40% through integrated AI.
Medication safety and clinical nutrition programmes delivering measurable harm prevention and cost reduction through analytics and decision support.
Whether you are evaluating a platform, planning a digital health programme, or advising on a healthcare investment in an emerging market, a direct conversation is the right place to start.